Difference between revisions of "CT Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
Line 14: Line 14:
 
:::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]]
 
:::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]]
 
::* [[Lung Density Biomarker Ctte]]
 
::* [[Lung Density Biomarker Ctte]]
::* [https://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte|  CT Small Lung Nodule Biomarker Committee]
+
::* [[https://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte|  CT Small Lung Nodule Biomarker Committee]]
::* [https://qibawiki.rsna.org/index.php/CT_Angiography_Biomarker_Ctte|  CT Angiography Biomarker Committee]
+
::* [[https://qibawiki.rsna.org/index.php/CT_Angiography_Biomarker_Ctte|  CT Angiography Biomarker Committee]]
  
 
==Meetings==
 
==Meetings==
  
 
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.
 
* Zoom calls are held Quarterly. Please contact RSNA Staff for details.

Revision as of 22:47, 17 May 2022

Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
RSNA Staff Support: Julie Lisiecki

Scope

The CT Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of CT Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees

Meetings

  • Zoom calls are held Quarterly. Please contact RSNA Staff for details.